Zimmer Holdings Inc.
345 East Main Street
Warsaw,
IN 46580
United States - Map
Phone: 574-267-6131
Fax: 574-372-4988
Web Site: http://www.zimmer.com
| Zimmer Holdings, Inc., through its subsidiaries, engages in the design, development, manufacture, and marketing of orthopaedic and dental reconstructive implants, spinal implants, trauma products, and related surgical products in the Americas, Europe, and Asia Pacific. The company offers orthopaedic reconstructive implants that restore joint function lost due to disease or trauma in joints such as knees, hips, shoulders, and elbows; dental reconstructive implants, which restore function and aesthetics in patients who have lost teeth due to trauma or disease; spinal implants that are used by Orthopaedic surgeons and neurosurgeons in the treatment of degenerative diseases, deformities, and trauma; and trauma products, which are used primarily to reattach or stabilize damaged bone and tissue to support the bodys natural healing process. It also offers surgical products, including supplies and instruments designed to aid in orthopaedic surgical procedures and post-operation rehabilitation. The company sells its products to musculoskeletal surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers and agents, and healthcare purchasing organizations. It markets and sells its products through healthcare institutions, such as hospitals or direct channel accounts, stocking distributors, healthcare dealers, and dental practices and dental laboratories. The company was founded in 1927 and is headquartered in Warsaw, Indiana. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. David Dvorak , 46
Chief Exec. Officer, Pres |
$
1.43M |
$
0 | Mr. James T. Crines , 50
Chief Financial Officer and Exec. VP of Fin. |
$
730.00K |
$
0 | Mr. Stephen H. L. Ooi , 56
Pres of Asia Pacific |
$
586.00K |
$
931.00K | Mr. Bruno A. Melzi , 62
Chairman of Europe Africa & Middle East |
$
887.00K |
$
478.00K | Dr. Cheryl R. Blanchard Ph.D., 46
Chief Scientific Officer and Sr. VP of R&D |
$
582.00K |
$
0 |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.63% Nasdaq 
0.67 (1.19%) 
Profile
